Wellcome Sanger Institute GENOME RESEARCH LIMITED (SANGER)

The Wellcome Sanger Institute, operated by Genome Research Limited, is a globally leading genomics research center located on the Wellcome Genome Campus near Cambridge, UK. Its mission is to advance understanding of biology and improve human health by decoding the genetic basis of life and disease. The institute is internationally renowned for pioneering contributions to genome sequencing, disease genomics, and evolutionary biology, and serves as a cornerstone of large-scale, data-driven biology.
The Sanger Institute’s infrastructure includes one of the world’s largest Illumina® DNA sequencing facilities, capable of producing over 3,000 terabases of sequence data per month. The institute’s IT infrastructure—featuring 64PB of storage and 38,000 processing cores—is among the most powerful in the life sciences, ensuring seamless support for data generation, analysis, and open-access dissemination.
Doctoral candidates benefit from purpose-built laboratories and unique facilities such as the Lehner Faculty Lab, which is equipped for high-throughput mutagenesis and functional genomics. The Sanger Institute has a robust record in doctoral training and EU-funded projects, including participation in nearly 80 EC projects and multiple MSCA ITNs such as ENLIGHT-TEN, MELGEN, and ENLIGHT-TENplus. Its continued leadership in cutting-edge genomics and training affirms its commitment to developing the next generation of genome scientists.